Key result
Aberrant microRNA expression drives pathophysiological processes in atherosclerosis and cardiovascular disease.
Answers are grounded in this paper and cite their sources.
MicroRNAs are endogenously expressed small noncoding RNAs that regulate gene expression at the post-transcriptional level. MicroRNAs have emerged as key regulators of several physiological and pathophysiological processes in the cardiovascular system. Aberrant expression of microRNAs has been implicated in the pathophysiological processes underlying the development of atherosclerosis and cardiovascular disease, including change in endothelial function, vascular smooth muscle cell proliferation and migration, macrophage function, and foam cell formation. In this review, we summarize the recent data showing the roles of microRNAs in cell studies, studies on atherosclerotic mice, and human studies.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2012) conducted a review in Atherosclerosis and cardiovascular disease. MicroRNAs was evaluated. Aberrant expression of microRNAs has been implicated in the pathophysiological processes underlying the development of atherosclerosis and cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: